Listing of Equity Shares of Ganga Pharmaceuticals Limited

• Notice No: 20160219-25
• Notice Date: 19 Feb 2016
• Category: Company related
• Segment: SME

Trading Members of the Exchange are hereby informed that effective from Monday, February 22, 2016 the Equity Shares of Ganga Pharmaceuticals Limited shall be listed and admitted to dealings on the SME Platform of Exchange in the list of ‘MT’ Group of Securities.

Name of the company	Securities	Market Lot	Scrip Code
Ganga Pharmaceuticals Limited	40,61,500 equity shares of Rs. 10/- each fully paid up Distinctive Nos. 1 to 40,61,500	8,000 Shares	539680
Registered Office: 1 - A, 802, N.G. Suncity Ph II, Kandivali East, Mumbai 400101, Maharashtra, India Tel No: [phone]/444 Fax No: [phone] Email: [e-mail] Website: www.ayurvedganga.com	Abbreviated name on bolt system GANGAPHARM	Scrip ID on BOLT System GANGAPHARM	ISIN No. INE615T01017
Issue Price: Rs. 15/- per share (Face Value of Rs.10/- with Premium of Rs. 5/-)		Date of Allotment in the public issue: February 17, 2016

1.    Trading Members may note that as per the guidelines issued by SEBI dated 16^th February, 2000, securities of the company will only be traded in Dematerialised form. Trades effected in this scrip will be in minimum market lot (i.e. 8,000 equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of atleast one month.

2.     The trading in the scrip shall continue to remain in Trade-for-Trade segment till further notice since 100% of promoter shareholding of the company is not in demat form, as per extent SEBI guidelines.

3.     Trading Members are requested to note that the above security will be available for trading in continuous trading session.

4.    Trading Members may note that the shares bearing the distinctive numbers, the details of which are attached as Annexure I, are not transferable till the date(s) mentioned against them and would not be a good delivery in the market till then. The company has informed the Exchange that in respect of shares in physical form, the respective share certificates have been enfaced with their non-transferability. The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depository’s records.

5.      A copy of shareholding pattern submitted by the company is enclosed as Annexure II.

6.     The company’s financial year ending is March 31.

7.     All shares are ranking pari-passu including dividend entitlement.

8.    The Market Maker to the issue as mentioned in the prospectus is given below:

Alacrity Securities Limited

101, 1st Floor, Hari Dharshan,

B Wing, Bhogilal Fadia Road,

Kandivali (West),

Mumbai - 400 067

Tel: [phone];

Fax: [phone]

E-mail: [e-mail]

Website: www.alacritysec.com

SEBI Registration No.: INB010909837

9.    The Registrar to the issue as mentioned in the prospectus is given below:

Karvy Computershare Private Limited

Karvy Selenium Tower B, Plot 31-32,

Gachibowli, Financial District,

Nanakramguda,

Hyderabad 500 032

Tel : + 91 40 6716 2222/ 1-800-3454001

Fax : [phone]

Website: www.karishma.karvy.com

E-mail: [e-mail]

Investor Grievance e-mail: [e-mail]

SEBI Registration: INR000000221

In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:

a) At the company: Mr. Mustafa Shabbir Badami, Company Secretary & Compliance Officer	Corporate Office Address: Gangatat, Dhanvantary Marg, Gopchar Pada, Virar (East), Mumbai 401 303, India Tel No: [phone]/444 Fax No: [phone] Email: [e-mail] Website: www.ayurvedganga.com
b) At the Exchange:      Rupal Khandelwal      Manager	Tel.: [phone]

Bhushan Mokashi

Dy. General Manager

Friday, February 19, 2016